» Articles » PMID: 36544188

Robust Generation of Human-chambered Cardiac Organoids from Pluripotent Stem Cells for Improved Modelling of Cardiovascular Diseases

Overview
Publisher Biomed Central
Date 2022 Dec 21
PMID 36544188
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tissue organoids generated from human pluripotent stem cells are valuable tools for disease modelling and to understand developmental processes. While recent progress in human cardiac organoids revealed the ability of these stem cell-derived organoids to self-organize and intrinsically formed chamber-like structure containing a central cavity, it remained unclear the processes involved that enabled such chamber formation.

Methods: Chambered cardiac organoids (CCOs) differentiated from human embryonic stem cells (H7) were generated by modulation of Wnt/ß-catenin signalling under fully defined conditions, and several growth factors essential for cardiac progenitor expansion. Transcriptomic profiling of day 8, day 14 and day 21 CCOs was performed by quantitative PCR and single-cell RNA sequencing. Endothelin-1 (EDN1) known to induce oxidative stress in cardiomyocytes was used to induce cardiac hypertrophy in CCOs in vitro. Functional characterization of cardiomyocyte contractile machinery was performed by immunofluorescence staining and analysis of brightfield and fluorescent video recordings. Quantitative PCR values between groups were compared using two-tailed Student's t tests. Cardiac organoid parameters comparison between groups was performed using two-tailed Mann-Whitney U test when sample size is small; otherwise, Welch's t test was used. Comparison of calcium kinetics parameters derived from the fluorescent data was performed using two-tailed Student's t tests.

Results: Importantly, we demonstrated that a threshold number of cardiac progenitor was essential to line the circumference of the inner cavity to ensure proper formation of a chamber within the organoid. Single-cell RNA sequencing revealed improved maturation over a time course, as evidenced from increased mRNA expression of cardiomyocyte maturation genes, ion channel genes and a metabolic shift from glycolysis to fatty acid ß-oxidation. Functionally, CCOs recapitulated clinical cardiac hypertrophy by exhibiting thickened chamber walls, reduced fractional shortening, and increased myofibrillar disarray upon treatment with EDN1. Furthermore, electrophysiological assessment of calcium transients displayed tachyarrhythmic phenotype observed as a consequence of rapid depolarization occurring prior to a complete repolarization.

Conclusions: Our findings shed novel insights into the role of progenitors in CCO formation and pave the way for the robust generation of cardiac organoids, as a platform for future applications in disease modelling and drug screening in vitro.

Citing Articles

Synthetic embryology of the human heart.

Paredes-Espinosa M, Paluh J Front Cell Dev Biol. 2025; 12:1478549.

PMID: 39935786 PMC: 11810959. DOI: 10.3389/fcell.2024.1478549.


Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.

Wang Y, Hou Y, Hao T, Garcia-Contreras M, Li G, Cretoiu D Biomater Transl. 2025; 5(4):337-354.

PMID: 39872935 PMC: 11764187. DOI: 10.12336/biomatertransl.2024.04.002.


Revolutionizing cardiovascular research: Human organoids as a Beacon of hope for understanding and treating cardiovascular diseases.

Li J, Li Y, Song G, Wang H, Zhang Q, Wang M Mater Today Bio. 2025; 30():101396.

PMID: 39802826 PMC: 11719415. DOI: 10.1016/j.mtbio.2024.101396.


In Vitro Models of Cardiovascular Disease: Embryoid Bodies, Organoids and Everything in Between.

Stougiannou T, Christodoulou K, Karangelis D Biomedicines. 2025; 12(12.

PMID: 39767621 PMC: 11726960. DOI: 10.3390/biomedicines12122714.


Trends and challenges in organoid modeling and expansion with pluripotent stem cells and somatic tissue.

Ge J, Wang Y, Li Q, Liu F, Lei Q, Zheng Y PeerJ. 2024; 12:e18422.

PMID: 39619184 PMC: 11608026. DOI: 10.7717/peerj.18422.


References
1.
Ho B, Pek N, Soh B . Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells. Int J Mol Sci. 2018; 19(4). PMC: 5979503. DOI: 10.3390/ijms19040936. View

2.
Soh B, Ng S, Wu H, Buac K, Park J, Lian X . Endothelin-1 supports clonal derivation and expansion of cardiovascular progenitors derived from human embryonic stem cells. Nat Commun. 2016; 7:10774. PMC: 4786749. DOI: 10.1038/ncomms10774. View

3.
Pang J, Ho B, Chan W, Soh B . Insights to Heart Development and Cardiac Disease Models Using Pluripotent Stem Cell Derived 3D Organoids. Front Cell Dev Biol. 2021; 9:788955. PMC: 8675211. DOI: 10.3389/fcell.2021.788955. View

4.
Giacomelli E, Meraviglia V, Campostrini G, Cochrane A, Cao X, van Helden R . Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease. Cell Stem Cell. 2020; 26(6):862-879.e11. PMC: 7284308. DOI: 10.1016/j.stem.2020.05.004. View

5.
Ravenscroft S, Pointon A, Williams A, Cross M, Sidaway J . Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues. Toxicol Sci. 2016; 152(1):99-112. PMC: 4922542. DOI: 10.1093/toxsci/kfw069. View